Bridgewater Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Sell
528
-64
-11% -$21K 0.01% 438
2025
Q4
$219K Buy
+592
New +$200K 0.01% 425
2025
Q3
Sell
-720
Closed -$208K 443
2025
Q2
$208K Buy
720
+148
+26% +$59.5K 0.02% 421
2025
Q1
$237K Buy
+572
New +$230K 0.02% 364

Other funds holding ELV

Bridgewater Advisors's ELV Position: Q1 2026 in Review

Bridgewater Advisors reduced its Elevance Health (ELV) stake by 11% in Q1 2026, selling an estimated $21K and leaving 528 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #438.

Bridgewater Advisors first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. The position peaked at $237K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Bridgewater Advisors held 528 shares of Elevance Health worth $211K as of Q1 2026.
  • Bridgewater Advisors sold 64 Elevance Health shares in Q1 2026, an estimated $21K.
  • Elevance Health made up 0.01% of Bridgewater Advisors's portfolio in Q1 2026, its #438 holding.
  • Bridgewater Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
  • Bridgewater Advisors's Elevance Health position peaked at $237K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.